Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
MUCINEX
Generic name / active ingredient
guaifenesin
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-24

Copy from the pack in hand

Source-linked reading points

  • Check MUCINEX, guaifenesin, 600 mg per tablet, the extended-release bi-layer oral tablet, NDC 63824-008-32, the 20-tablet blister-pack carton and target market together. 600 mg is the labelled strength for this exact tablet, not a web answer to anyone's tablet count.
  • The label says not to break, chew or crush the extended-release tablet. This makes “extended release” an identity and label-reading point, not permission to split, grind, convert or substitute it using experience with an ordinary tablet. Whether and how a product can be split must be checked against the current label for the actual pack with a pharmacist or clinician.
  • The label flags persistent or chronic cough, a cough with much mucus, a cough lasting more than seven days, recurrence, or cough with fever, rash or persistent headache for further action through the label and professional channels. Do not turn these cues into a self-directed increase, continuation, stopping, combination or substitution plan from a website.
  • The MUCINEX name, package image, white-and-blue colour or imprint can only help locate a source; they cannot authenticate a product, establish current approval or decide individual suitability. With suspected overdose, breathing difficulty, worsening symptoms or uncertainty about the next step, prioritise local medical support.

Reviewed presentation examples — compare every field

  • Guaifenesin 600 mg per tablet; 20-tablet blister-pack cartonNDC 63824-008-32

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-24
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image